Expanding Medicare beneficiary access to FDA-approved non-opioid pain management
The NOPAIN Act is a bipartisan law aimed at reducing opioid use and preventing addiction among Medicare beneficiaries. It expands Medicare beneficiary access to FDA-approved non-opioid pain management options in hospital and ASC-based outpatient settings, providing a route through which Medicare can provide separate reimbursement for these therapies. Through the NOPAIN Act, Enovis is able to offer the DonJoy IceMan continuous cold therapy devices as an approved option, and one that is separately reimburseable by Medicare for hospital outpatient departments and ASC's.
Dr. Sarah Edwards discusses the NOPAIN Act.
DonJoy® IceMan®
Treating pain is a lot cooler with Medicare-Covered Cold Therapy.
IceMan® Motorized Cold Therapy will be eligible for separate Medicare payment in outpatient hospitals and ambulatory surgery centers that are paid via the Medicare Outpatient Prospective Payment System effective, January 1, 2026.
Read More about Cold Therapy for post-op care.
Learn more about what the NOPAIN act means for your facility.
Learn more about the
IceMan® Classic3
Learn more about the
IceMan® Clear3
Billing Guidelines and Example Forms
For more information on IceMan and the CMS on the 2026 Final Rule visit:
https://public-inspection.federalregister.gov/2025-20907.pdf
THIS DEVICE CAN BE COLD ENOUGH TO CAUSE SERIOUS INJURY.
Please read and understand all warnings and instructions for use before using the device. DO NOT use this device without a prescription and direction from a physician.